Tristel TSTL.L · GBp

Its shares trade on LSE under the ticker TSTL.L. It has been listed since 1 June 2005. In the fiscal year to 30 June 2026, it reported revenue of £51.1m and net income of £8.0m. At that date it held total assets of £48.3m and shareholders' equity of £35.7m.

Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire. The company went IPO on 2005-06-01. The firm's technology is a chlorine dioxide formulation. The firm operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used primarily for infection control in hospitals. The segments products are marketed under the brand, Tristel. The Animal Healthcare segment relates to manufacture and sale of disinfection and cleaning products into veterinary and animal welfare sectors. The segments products are marketed under the brand, Anistel. The Contamination Control segment addresses the pharmaceutical and personal care product manufacturing industries. The segments products are marketed under the brand, Crystel. Its manufacturing facility is located in Newmarket, Cambridgeshire.

Figures and description from our data supplier, not checked against the company's own report.

• Dr. Bruno HolthofIndependent Non-Executive Chairman of the Board£84,000
• Mr. Matthew Giovanni SassoneChief Executive Officer, Executive Director, since 2024
• Ms. Anna WasylChief Financial Officer
• Ms. Heidi AllardCompany Secretary
• Mr. Tom JenkinsNon-Executive Director£42,000
• Mr. David OrrNon-Executive Director£42,000
• Ms. Isabel NapperSenior Independent Non-Executive Director£42,000
• Ms. Caroline StephensIndependent Non-Executive Director£42,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.